ABT Expands Pure Bliss Line of Products for Advanced Infant Nutrition
https://www.zacks.com/stock/news/2328328/abt-expands-pure-bliss-line-of-products-for-advanced-infant-nutrition?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2328328
Aug 28, 2024 - Abbott announces the expansion of its Pure Bliss by Similac line of products for infant nutrition with Organic and Organic A2 Milk infant formulas.
0
Quest Diagnostics Expands in North America With New Acquisition
https://www.zacks.com/stock/news/2327760/quest-diagnostics-expands-in-north-america-with-new-acquisition?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2327760
Aug 27, 2024 - DGX acquires 100% of LifeLabs from OMERS, at approximately $1 billion. It will help LifeLabs to improve healthcare for Canadians.
0
Reasons to Retain QIAGEN Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2327738/reasons-to-retain-qiagen-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2327738
Aug 27, 2024 - Investors remain optimistic about QGEN due to its progress in test menu expansion and impressive prospects within its molecular diagnostics segments.
0
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
https://www.zacks.com/stock/news/2326596/microbot-medical-mbot-inks-new-phase-2-agreement-for-liberty?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2326596
Aug 23, 2024 - Microbot Medical (MBOT) signs a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using LIBERTY.
0
Reasons to Retain Thermo Fisher (TMO) in Your Portfolio Now
https://www.zacks.com/stock/news/2325050/reasons-to-retain-thermo-fisher-tmo-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325050
Aug 21, 2024 - Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).
0
Omnicell (OMCL) Introduces Central Med Automation Service
https://www.zacks.com/stock/news/2325052/omnicell-omcl-introduces-central-med-automation-service?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2325052
Aug 21, 2024 - Omnicell (OMCL) has come up with a subscription-based solution named Central Med Automation Service. The solution is expected to improve inventory visibility, scalability and patient safety.
0
Paragon 28 (FNA) Expands SMART 28 Ecosystem With New Launches
https://www.zacks.com/stock/news/2324185/paragon-28-fna-expands-smart-28-ecosystem-with-new-launches?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2324185
Aug 20, 2024 - Paragon 28 (FNA) strengthens its position in the foot and ankle device market with the launch of the SMART28 Case Management Portal and the SMART Bun-Yo-Matic device.
0
Compelling Reasons to Hold Molina Healthcare (MOH) Stock Now
https://www.zacks.com/stock/news/2324006/compelling-reasons-to-hold-molina-healthcare-moh-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2324006
Aug 19, 2024 - Molina Healthcare (MOH) remains well-poised for growth, attributable to membership growth in Medicaid and Medicare businesses. Buyouts and an adequate cash balance remain other benefits.
0
Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now
https://www.zacks.com/stock/news/2323390/reasons-to-add-intuitive-surgical-isrg-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2323390
Aug 16, 2024 - Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
0
Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
https://www.zacks.com/stock/news/2322538/accuray-s-aray-radixact-for-cancer-treatment-debuts-in-us?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322538
Aug 15, 2024 - Accuray's (ARAY) Radixact System with VitalHold technology is set to enhance precision and comfort in radiation therapy.
0